Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |